ATE167522T1 - Monoklonale antikörper gegen mögliche hcv- hüllregionen und methoden diese zu benutzen - Google Patents

Monoklonale antikörper gegen mögliche hcv- hüllregionen und methoden diese zu benutzen

Info

Publication number
ATE167522T1
ATE167522T1 AT92906219T AT92906219T ATE167522T1 AT E167522 T1 ATE167522 T1 AT E167522T1 AT 92906219 T AT92906219 T AT 92906219T AT 92906219 T AT92906219 T AT 92906219T AT E167522 T1 ATE167522 T1 AT E167522T1
Authority
AT
Austria
Prior art keywords
monoclonal antibodies
methods
antibodies against
against possible
hcv envelope
Prior art date
Application number
AT92906219T
Other languages
English (en)
Inventor
Mary S Gibadlo
Joan D Tyner
Larry T Mimms
David S Vallari
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Application granted granted Critical
Publication of ATE167522T1 publication Critical patent/ATE167522T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—RNA viruses
    • C07K16/116—Togaviridae (F); Matonaviridae (F); Flaviviridae (F)
    • C07K16/118—Hepatitis C virus; GB virus C [GBV-C]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C12N5/12—Fused cells, e.g. hybridomas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT92906219T 1991-01-31 1992-01-30 Monoklonale antikörper gegen mögliche hcv- hüllregionen und methoden diese zu benutzen ATE167522T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US64847591A 1991-01-31 1991-01-31

Publications (1)

Publication Number Publication Date
ATE167522T1 true ATE167522T1 (de) 1998-07-15

Family

ID=24600936

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92906219T ATE167522T1 (de) 1991-01-31 1992-01-30 Monoklonale antikörper gegen mögliche hcv- hüllregionen und methoden diese zu benutzen

Country Status (11)

Country Link
EP (1) EP0569537B1 (de)
JP (1) JP3483555B2 (de)
KR (1) KR930703361A (de)
AT (1) ATE167522T1 (de)
AU (1) AU662517B2 (de)
CA (1) CA2101534C (de)
DE (1) DE69225960T2 (de)
DK (1) DK0569537T3 (de)
ES (1) ES2118129T3 (de)
HK (1) HK1012838A1 (de)
WO (1) WO1992013892A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2188583T3 (es) 1991-06-24 2003-07-01 Chiron Corp Polipeptidos para el virus de la hepatitis c (hcv).
JP3217600B2 (ja) * 1994-07-12 2001-10-09 株式会社先端生命科学研究所 非ａ非ｂ型肝炎ウイルス関連抗原のイムノアッセイ、それに使用するモノクローナル抗体、およびこの抗体を産生するハイブリドーマ
ES2174957T5 (es) * 1994-07-29 2006-12-16 Innogenetics N.V. Proteinas purificadas de envoltura de virus de la hepatitis c para uso diagnostico y terapeutico.
EP0947525A1 (de) 1998-03-27 1999-10-06 Innogenetics N.V. Epitope in der viralen Hüllproteine und spezifische Antikörper gegen diese Epitope: Verwendung für die detektion von viralantigene im empfängergewebe
ES2279766T3 (es) * 1999-07-28 2007-09-01 Novartis Vaccines And Diagnostics, Inc. Sistemas de deteccion por inmunoensayos del antigeno viral de hepatitis c.
US6815160B1 (en) 1999-07-28 2004-11-09 Chiron Corporation Hepatitis C viral antigen immunoassay detection systems
JP5642972B2 (ja) 2007-02-21 2014-12-17 ユニバーシティー オブ マサチューセッツＵｎｉｖｅｒｓｉｔｙ ｏｆ Ｍａｓｓａｃｈｕｓｅｔｔｓ Ｃ型肝炎ウイルス（ｈｃｖ）に対するヒト抗体およびその使用
US20100291545A1 (en) 2007-07-25 2010-11-18 Takaji Wakita Antibody having inhibitory activity on infection with hepatitis c virus (hcv) and use thereof
CN102227445B (zh) 2008-09-30 2014-12-17 东丽株式会社 结合丙型肝炎病毒的包膜蛋白2的抗体以及利用所述抗体鉴定丙型肝炎病毒的基因型的方法
EP2495256A4 (de) 2009-10-30 2013-09-25 Toray Industries Antikörper mit hemmender wirkung auf infektionen mit hepatitis-c-virus (hcv) und seine verwendung

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0071640B1 (de) * 1981-02-11 1986-06-04 Connaught Laboratories Incorporated Nicht-a, nicht-b hepatitisvirus
JPH02500880A (ja) * 1987-11-18 1990-03-29 カイロン　コーポレイション Ｎａｎｂｖの診断用薬およびワクチン
KR0185373B1 (ko) * 1989-03-17 1999-05-01 로버트 피. 블랙버언 Hcv 폴리단백질에서 유래되는 hcv 아미노산 서열 부분을 포함하는 폴리펩티드 및 그 사용
CA2032907C (en) * 1989-12-22 2002-05-14 Richard R. Lesniewski Hepatitis c assay
AU7672991A (en) * 1990-04-03 1991-10-30 Southwest Foundation For Biomedical Research Purified hcv and hcv proteins and peptides
CA2049679C (en) * 1990-08-24 2005-06-21 Sushil G. Devare Hepatitis c assay utilizing recombinant antigens
ATE318309T1 (de) * 1990-11-03 2006-03-15 Dade Behring Marburg Gmbh Hcv-spezifische peptide, mittel dazu und ihre verwendung
JP3242402B2 (ja) * 1990-11-07 2001-12-25 アボット・ラボラトリーズ Ｃ型肝炎ウイルスに対するモノクローナル抗体およびその使用法

Also Published As

Publication number Publication date
CA2101534C (en) 2004-01-20
DE69225960T2 (de) 1999-01-21
KR930703361A (ko) 1993-11-29
EP0569537A4 (en) 1994-10-05
JPH06505389A (ja) 1994-06-23
ES2118129T3 (es) 1998-09-16
EP0569537A1 (de) 1993-11-18
WO1992013892A1 (en) 1992-08-20
DK0569537T3 (da) 1999-04-06
DE69225960D1 (de) 1998-07-23
EP0569537B1 (de) 1998-06-17
AU1362792A (en) 1992-09-07
AU662517B2 (en) 1995-09-07
JP3483555B2 (ja) 2004-01-06
CA2101534A1 (en) 1992-08-01
HK1012838A1 (en) 1999-08-06

Similar Documents

Publication Publication Date Title
EP0603307A4 (de) Monoklonale antikörper gegen putative hcv-e2/ns1-proteine und verfahren zu ihrer verwendung.
ATE239756T1 (de) Humaner monoklonaler antikörper gegen hepatitis b virus oberflächen antigen (hbvsag)
FI942369A0 (fi) Hepatitis-C-virustesti
NZ237666A (en) Hiv envelope (env) polypeptides, antibodies and compositions for treating aids
DE60224346D1 (de) Monoklonales Antikörper gegen das HCV Kernantigen
ATE336512T1 (de) Epitope in der viralen hüllproteine und spezifische antikörper gegen diese epitope: verwendung für die detektion von hcv viralantigene im empfängergewebe
ATE167522T1 (de) Monoklonale antikörper gegen mögliche hcv- hüllregionen und methoden diese zu benutzen
DE69532062D1 (de) Immuntests von nicht-A, nicht-B Hepatitisvirus-verwandten Antigenen, monoklonale Antikörper und diese synthetisierende Hybridome
DE69224134D1 (de) Monoklonale Antikörper gegen Hepatitis-C-Virus
DK1002092T3 (da) Mimotoper af hypervariabel region 1 af E2-glycoproteinet fra HCV og anvendelser deraf
ATE174060T1 (de) Monoklonale antikörper gegen mutmassliche hepatitis c-virus ns5-proteine und ihre anwendungsmethoden
ATE178096T1 (de) Monoklonale antikörper gegen den hepatitis c- virus und verfahren diese zu benutzen
BR0204612C1 (pt) anticorpos monoclonais antinúcleo de hcv
NO924137L (no) Monoklonale anti-igm-antistoffer, deres fremstilling og anvendelse, og hybridomas for fremstilling av de samme

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee